Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Zhejiang Tianrui Pharmaceutical Co. Ltd., commonly referred to as Tianrui Pharma, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, primarily focusing on active pharmaceutical ingredients (APIs) and finished dosage forms.
With a strong operational presence across various regions in China and beyond, Tianrui Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, distinguished by their adherence to stringent international standards.
Tianrui Pharma has achieved notable recognition in the market, positioning itself as a trusted supplier in the global pharmaceutical landscape, thanks to its robust research and development capabilities and a dedication to enhancing healthcare outcomes.
-24 vs industry average
Zhejiang Tianrui Pharmaceutical Co. Ltd’s score of 18 is lower than 11% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Zhejiang Tianrui Pharmaceutical Co. Ltd yet.
Zhejiang Tianrui Pharmaceutical Co. Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company.
As a result, there is no available information on their climate commitments or initiatives aimed at reducing carbon emissions. The company may be in the early stages of developing its sustainability strategy or may not have publicly disclosed its environmental impact data.
In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific data or commitments from Zhejiang Tianrui Pharmaceutical Co. Ltd, it is challenging to assess their position within this evolving landscape.
No climate goals have been disclosed for Zhejiang Tianrui Pharmaceutical Co. Ltd yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more